SK bioscience inked a manufacturing deal with MSD for an Ebola vaccine candidate.

Under the contract manufacturing organization (CMO) deal, the New Jersey-based company will transfer technology for the candidate to SK bioscience so that the Korean company can make it at the L House, its vaccine manufacturing site in Andong, North Gyeongsang.